newsfilter
← Latest News
PR Newswire·

Synaptogenix Announces Participation at the H.C. Wainwright 23rd Annual Global Investment Conference

NEW YORK, Sept. 10, 2021 /PRNewswire/ -- Synaptogenix, Inc (NASDAQ:SNPX), an emerging biopharmaceutical company developing regenerative therapeutics for neurodegenerative disorders, today announced it will be featured as a presenting company at the H.C.